Which enzymes are inhibited by lead?

Prepare for the NBME Form 27 Test. Practice with extensive flashcards and multiple-choice questions that include helpful hints and detailed explanations. Ensure success on your exam!

Multiple Choice

Which enzymes are inhibited by lead?

Explanation:
Lead is a well-known environmental toxin that interferes with several enzymatic processes in the body, particularly those involved in heme synthesis. The correct answer identifies two key enzymes that are inhibited by lead: ferrochelatase and ALA dehydratase. Ferrochelatase is responsible for catalyzing the final step in heme synthesis, which involves the insertion of iron into protoporphyrin IX to form heme. Inhibition of this enzyme can lead to an accumulation of protoporphyrin and a reduction in the production of hemoglobin, resulting in anemia. ALA dehydratase, on the other hand, plays a crucial role early in the heme synthesis pathway by catalyzing the condensation of two molecules of delta-aminolevulinic acid (ALA) to form porphobilinogen. The inhibition of this enzyme by lead results in the accumulation of ALA, which is a neurotoxin and contributes to the neurological symptoms associated with lead poisoning. The combination of inhibiting these two enzymes disrupts the normal production of heme, leading to various clinical manifestations, including anemia and neurological impairment, which are hallmark features of lead poisoning.

Lead is a well-known environmental toxin that interferes with several enzymatic processes in the body, particularly those involved in heme synthesis. The correct answer identifies two key enzymes that are inhibited by lead: ferrochelatase and ALA dehydratase.

Ferrochelatase is responsible for catalyzing the final step in heme synthesis, which involves the insertion of iron into protoporphyrin IX to form heme. Inhibition of this enzyme can lead to an accumulation of protoporphyrin and a reduction in the production of hemoglobin, resulting in anemia.

ALA dehydratase, on the other hand, plays a crucial role early in the heme synthesis pathway by catalyzing the condensation of two molecules of delta-aminolevulinic acid (ALA) to form porphobilinogen. The inhibition of this enzyme by lead results in the accumulation of ALA, which is a neurotoxin and contributes to the neurological symptoms associated with lead poisoning.

The combination of inhibiting these two enzymes disrupts the normal production of heme, leading to various clinical manifestations, including anemia and neurological impairment, which are hallmark features of lead poisoning.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy